Why does benzodiazepine withdrawal make the heart race, and when does it need same-day care?

Benzodiazepines quiet the nervous system, and withdrawal lets it run unopposed.

Benzodiazepines calm the nervous system by enhancing gamma-aminobutyric acid (GABA), the brain’s main quieting chemical. Professor C. Heather Ashton explains in Chapter I of the Ashton Manual that GABA tells the neurons it reaches to slow down or stop firing, and every benzodiazepine, from Xanax (alprazolam) to Valium (diazepam), amplifies that signal. Z-drugs such as Ambien (zolpidem) act by the same mechanism, the Manual notes, and behave the same way.

Taken daily for months, the drug becomes part of the nervous system’s settings. The brain appears to compensate for the extra calming by turning its own alerting systems up, and when the dose falls, that compensation runs unopposed for a while. The result is an overactive autonomic nervous system: a faster pulse, higher blood pressure, palpitations, chest tightness, sweating, and tremor.

Chapter III of the Manual lists palpitations among the physical withdrawal symptoms in its Table 1, names pounding heart and rapid pulse in its discussion of panic, and Professor Ashton is direct about them. They do not signify heart or lung disease, she writes, but are simply the expression of an overactive autonomic nervous system.

Withdrawal is not only what happens when someone stops abruptly. It also shows up, usually more mildly, after each step of a slow taper, and with a short-acting drug it can appear between doses while the person is still taking it, which the Manual attributes to tolerance and which patients call interdose withdrawal. So, a pounding heart the morning after a dose reduction is the expected shape of the problem.

A pounding heart in withdrawal is usually a healthy heart with too much to do.

Most patients who reach this page took the medication as prescribed, often for years, and now find that every reduction brings symptoms. That is physical dependence, a condition the medication itself created, and dependence is not addiction. The right response is a gradual, medically supervised taper, not a treatment model built for a different problem.

The same distinction applies to the heart. Withdrawal does not give a person heart disease. It gives a healthy heart too much to do for a while.

Professor Ashton’s advice in Chapter III is to treat these sensations the way the body would after running for a bus, because that is roughly what they are. The heart is not failing. It is being asked to sprint while the person sits still.

Palpitations, pounding, and chest tightness usually ease when the taper slows.

Patients often describe a familiar sequence. A dose reduction, a few quiet days, then a stretch of pounding heartbeats, a tight chest, and lightheadedness on standing. The symptoms peak and fade as the nervous system settles at the new dose, and when they arrive with every step, the step was too big or the pace too fast.

Fortunately, the fix is usually within the patient’s control. Holding at the current dose until the body catches up, or making the next reduction smaller, takes the pressure off the autonomic system. The Ashton Manual, in Chapter II, suggests reductions of up to one tenth of the daily dose at a time and says plainly that the patient is usually the best judge of the pace.

The Maudsley Deprescribing Guidelines describe the same idea in a different shape: hyperbolic reductions, where each step is a fraction of the current dose rather than of the starting dose, so the steps shrink as the dose falls. Whatever the framework, the schedule belongs to the patient and the prescriber together.

Dr. Mark Leeds, an osteopathic physician and deprescribing specialist in Fort Lauderdale, Florida, also uses the crossover taper the Manual describes, moving from a short-acting drug to diazepam where it helps. Steadier blood levels smooth out the between-dose surges that set the heart pounding.

Can Ativan itself slow the heart?

Ativan (lorazepam) and its relatives are sedatives, so the honest answer is yes, in specific circumstances. At ordinary prescribed doses, a benzodiazepine has little effect on the resting pulse. In an overdose, or combined with alcohol or other medicines that depress the central nervous system, it can slow breathing, lower blood pressure, and slow the heart, and the United States Food and Drug Administration (FDA) warned against those combinations in its September 2020 boxed-warning update.

Yet, withdrawal does the opposite. Taking the drug away removes a sedative, and the nervous system swings toward a faster heart and higher blood pressure, never a slower one. So, a slow pulse during a taper is not something withdrawal explains, and it deserves a check for another cause: a different medication, a thyroid problem, or a rhythm disturbance of its own.

What about Klonopin (clonazepam)?

The physiology is the same for every benzodiazepine. Klonopin (clonazepam), Ativan, Xanax, and Valium all work through GABA, and all drive the same autonomic surge when the dose drops faster than the nervous system can follow. Klonopin’s longer half-life softens the between-dose dips but exempts no one from withdrawal, and it is a drug patients taper off of, not a tool for managing withdrawal from something else.

For a racing pulse on Klonopin, the answer is the same as for any benzodiazepine: a smaller step, or a hold, and a conversation with the prescriber. New or sustained palpitations, chest pain, or fainting are not taper-adjustment problems and need a doctor the same day.

What does a physician actually check?

A physician starts with the timeline. Symptoms that track dose reductions, appear within days of a step, and fade over a week or two point to withdrawal. Symptoms that arrive with exertion, wake a person from sleep with chest pressure, or continue unchanged whatever the dose point somewhere else.

The examination is ordinary medicine: pulse, blood pressure, home readings, a review of every other medication and supplement, and an electrocardiogram (ECG) when the history calls for one. Most patients need nothing more than that, and the answer is usually a slower taper.

These symptoms need same-day care.

A few symptoms should never wait for the next taper visit. Chest pain that comes on with exertion or spreads to the arm, jaw, or back is one. Fainting, a resting pulse that stays above about 120 beats per minute, shortness of breath at rest, and any seizure are the others.

Call 911 for a seizure, chest pain, fainting, or any medical emergency. The FDA’s 2020 update states that stopping a benzodiazepine abruptly, or reducing the dose too quickly, can cause withdrawal reactions including seizures that can be life-threatening, which is why abrupt stopping is never recommended. Anyone in crisis or thinking about suicide can call or text 988, the Suicide & Crisis Lifeline, at any hour.

A beta-blocker is the one adjunct the Manual supports for a pounding heart.

Unfortunately, the internet is full of confident drug lists for withdrawal, and most are wrong for this problem. Antiarrhythmic drugs and calcium channel blockers treat diseased rhythms and narrowed vessels. A healthy heart driven by an overactive nervous system has neither and does not need its rhythm regulated.

The one exception the Ashton Manual makes is a beta-blocker. Chapter III notes that palpitations and tremor can be controlled or lessened by beta-blocking drugs such as propranolol, and that some people take small regular doses through withdrawal. A beta-blocker blunts the effect of adrenaline on the heart, so the pounding fades, but it does nothing to the withdrawal underneath.

While it is a comfort measure for selected patients, it is not right for everyone, and the decision belongs in a consent conversation with the prescriber, risks first, with the right to decline. Slowing the taper remains the treatment, and a beta-blocker covers a hard stretch of it, never a reason to speed up.

Caffeine, nicotine, and alcohol all push in the wrong direction.

Caffeine and nicotine are stimulants. Each raises the pulse and blood pressure on its own, and in a nervous system that is already overactive, a second cup of coffee can turn a flutter into an hour of pounding. Cutting back gradually is sensible.

Alcohol is the one to watch, because it acts on the same GABA receptors as the benzodiazepine. A drink can quiet withdrawal symptoms for an evening and hand them back the next day, and the Manual in Chapter II warns against compensating for a falling benzodiazepine dose with alcohol, while Chapter III allows that a glass or two of wine is permissible and moderation is the key.

Withdrawal does not leave a healthy heart damaged.

It is fair to ask whether months of a pounding heart leave a mark. In the sense the question implies, they do not, in an otherwise healthy heart. The symptoms are functional, produced by a nervous system relearning to regulate itself without the drug, and they fade as it does.

Time is the main treatment, and there is no honest timeline for it: some patients feel steady within weeks of their last dose, and others describe waves of palpitations that come and go for months. Chapter III of the Manual says withdrawal symptoms characteristically wax and wane, and that the waves grow less severe and less frequent as time passes. In fact, the same system that produces the waves is the one that settles.

Dr. Leeds’ practice in Fort Lauderdale, Florida, offers one service: medically supervised benzodiazepine and z-drug tapering for patients in Florida, as a concierge practice rather than through insurance. The taper is gradual, patient-directed, and adapted to the person over months or longer, following the Ashton Manual crossover to diazepam where it helps, and heart symptoms are part of what he watches. Contact Dr. Leeds to ask about a supervised taper.

This article is educational. It is not medical advice, and reading it does not create a doctor-patient relationship. Decisions about starting, continuing, or tapering any medication should be made with your own physician.